News Channels

10 Aug 2020 Verastem Oncology Signs Definitive Agreement to Sell COPIKTRA® (duvelisib) Rights to Secura Bio to Focus on Development of VS-6766 and Defactinib in KRAS Mutant Solid Tumors
10 Aug 2020 AnaptysBio Reports Top-Line Data From Interim Analysis of ECLIPSE Phase 2 Clinical Trial of Etokimab in Chronic Rhinosinusitis with Nasal Polyps
10 Aug 2020 Pieris and Lilly Enter Into a Clinical Trial Collaboration to Evaluate Combination of PRS-343 With Ramucirumab and Paclitaxel in Gastric Cancer
10 Aug 2020 Genentech Provides Update on Phase III Studies of Etrolizumab in People With Moderately to Severely Active Ulcerative Colitis
08 Aug 2020 FDA Approves New Opioid for Intravenous Use in Hospitals, Other Controlled Clinical Settings
08 Aug 2020 Opdivo® (nivolumab) Plus Yervoy® (ipilimumab) Demonstrates Durable Survival Benefit vs. Chemotherapy in Patients with Previously Untreated Malignant Pleural Mesothelioma
08 Aug 2020 FDA Approves Genentech’s Evrysdi (risdiplam) for Treatment of Spinal Muscular Atrophy (SMA) in Adults and Children 2 Months and Older
07 Aug 2020 U.S. Food and Drug Administration Approves Lampit® (nifurtimox) for the Treatment of Chagas Disease in Children
07 Aug 2020 Novavax and Takeda Announce Collaboration for Novavax’ COVID-19 Vaccine Candidate in Japan: Takeda
07 Aug 2020 FDA Accepts Biogen’s Aducanumab Biologics License Application for Alzheimer's Disease with Priority Review
07 Aug 2020 CStone Announces CS1001 (Anti-PD-L1 mAb) Phase III Trial Met the Primary Endpoint as First-Line Treatment in Stage IV Squamous and Non-squamous Non-Small Cell Lung Cancer and Plans to Submit a New Drug Application
07 Aug 2020 ImmVira and Shanghai Pharma Announce Clinical Collaboration and License Agreement for Commercialization of Novel Intratumoral Oncolytic Virus Immunotherapies
07 Aug 2020 ViiV Healthcare announces FDA approval of an expanded indication for Dovato (dolutegravir/lamivudine), a complete two-drug regimen for virologically suppressed adults with HIV-1
07 Aug 2020 Genentech Provides Update On Phase III Study Of Tecentriq In Combination With Paclitaxel For People With Metastatic Triple-Negative Breast Cancer
07 Aug 2020 Editas Medicine Regains Full Global Rights to Ocular Medicines
07 Aug 2020 Novavax and Serum Institute of India Announce Development and Commercial Collaboration
07 Aug 2020 Novartis receives EC approval for new Xolair® indication to treat severe chronic rhinosinusitis with nasal polyps
06 Aug 2020 Denali Therapeutics Announces Decision to Advance DNL151 into Late Stage Clinical Studies in Parkinson’s Patients
06 Aug 2020 Tessa Therapeutics Announces Results from Two Independent Phase 1/2 Trials of Autologous CD30 CAR-T Cell Therapy in Patients with Relapsed or Refractory Hodgkin Lymphoma
06 Aug 2020 Precigen Triple-Gene Provides Six-month Follow-up Data from Phase I Study of INXN-4001, a Multigenic Investigational Therapeutic Candidate for Heart Failure

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up